Setting a Trap to Treat Stroke

Plucking a blood clot from the brain with a tiny wire trap is proving highly effective when a stroke hits — with quicker recovery and improved long-term results.

12:49 PM

Author | Kevin Joy

This article was updated on May 16, 2023.

Thrombectomy is a surgical procedure during which debilitating blood clots interrupting blood flow to the brain are ensnared and removed. By restoring blood flow to the brain, the aim is to minimize permanent brain damage and disability caused by stroke. This procedure often utilizes technology known as a stent retriever to clear the artery of clot and has helped many ischemic stroke patients achieve improved outcomes.

Inserted through an artery (typically in the groin), the collapsed stent can be expanded from inside a catheter once routed up to the brain's blocked blood vessel. A wirelike cage then "traps" the clot and ushers it out of the body. Catheter-based suction is also applied to improve the efficiency of the stent retrievers to open a blocked artery supplying the brain.

Using a 2-millimeter incision, the minimally invasive procedure takes about 60 to 90 minutes in most cases.

Stent retrievers can open blocked vessels 80 to 90% of the time — with "improved outcome" in 50 to 60% of patients after their discharge, says Neeraj Chaudhary, M.D., an associate professor radiology, neurosurgery, neurology and otolaryngology at the University of Michigan Medical School.

Growing usage and new indications

The first stent-retrievers were given approval from the United States Food and Drug Administration in 2012.

Although the technology has been available since then as part of the Neuro-Interventional portion of U-M's Comprehensive Stroke Program, it found wider adaptation nationwide after five studies on the procedure were published in 2015 in the New England Journal of Medicine.

This established thrombectomy as standard of care for patients suffering acute ischemic stroke with a blockage in one of the main arteries supplying the brain that were less than six hours out from when symptoms started. It was the first major advance in acute ischemic stroke therapy since intravenous tissue plasminogen activator (IV tPA), a clot busting medication, was shown to be effective in the mid-1990s.

Given that only a small fraction of stroke patients are eligible for thrombectomy based on the data from the 2015 clinical trials, ongoing efforts have been made to expand the number of people eligible for thrombectomy. In 2017, the DEFUSE 3 and DAWN trials published in the NEJM showed in a select subset of patients that thrombectomy could be beneficial up to 24 hours from when someone was last known to be well.

At the International Stroke Conference in February 2023, the SELECT 2 and ANGEL ASPECT studies suggested that even patients with larger strokes visible on imaging benefit from undergoing thrombectomy. Previously, there was concern that these patients may be too high-risk for the benefits of the thrombectomy to outweigh the risks. These two studies, both also published in the NEJM, showed markedly improved likelihood of good outcomes following thrombectomy as opposed to standard medical care.

“Ischemic strokes involving large vessel occlusion are often amongst the most disabling of strokes, and being able to offer thrombectomy to a larger and larger proportion of these patients is invaluable,” said Joseph Carrera, M.D., an assistant professor of neurology at U-M Medical School and medical director of the U-M Health Comprehensive Stroke Center. “I anticipate that the number of thrombectomies being performed could increase by up to 15-20% if eligibility from the recent large core thrombectomy trials are adopted nationwide.”

Ongoing research is being performed worldwide investigating use of thrombectomy in other populations of stroke patients to further increase the number of people that can receive this therapy.  Despite the potential for thrombectomy to be performed further out from symptom onset, Carrera says, the importance of seeking medical care immediately upon identification of stroke symptoms remains critical.

“The earlier you get to the hospital, the more likely it is that you will be candidate for one of our acute stroke therapies, and the more likely it is that those therapies will work,” he said.

More Articles About: Health Tech Stroke Treatment stroke
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories heart organ yellow blue
Health Lab
Irregular heartbeat after valve surgery increases risk of stroke, death
Postoperative atrial fibrillation, commonly known as Afib, has traditionally been viewed as benign and limited. But a study led by researchers at the University of Michigan Health Frankel Cardiovascular Center finds that postoperative atrial fibrillation increases the risk of strokes and permanent Afib — and is linked to worse long term survival — after heart valve surgery.
Brain image highlighting areas
Health Lab
Women stroke survivors believe they will receive worse care in the emergency room
National study examined health care perceptions of approximately 3,500 women, including those with and without a history of stroke
red lines with heart through it beige background
Health Lab
Research finds potential target for cardiovascular disease in diabetes
University of Michigan researchers found that the overproduction of neutrophil extracellular traps is an important contributing factor to vascular dysfunction in diabetes.
hospital staff emergency room patient rush
Health Lab
Nearly three-quarters of stroke patients requiring higher level of care wait over two hours for transfer
More than 70% of people experiencing a stroke who require a transfer wait longer than two hours to be transferred from the initial emergency department to hospitals with higher levels of care to receive time-sensitive care, a study finds.
drawing of pink brain and lines withering away blue background
Health Lab
Do you know what Moyamoya disease is?
Moyamoya disease is a rare condition that can cause blockage of the blood vessels in the brain and increase the risk of stroke. Learn more about this chronic disease from U-M Health’s neurologist and neurosurgeon as they explain more about how it is diagnosed and treated.
News Release
University of Michigan Health recognized by AHA for highest quality stroke care
University of Michigan Health has received the highest honor from the American Heart Association/American Stroke Association as a leader in stroke care in 2022, according to national guidelines and research. This marks the 9th consecutive year that the health system’s Comprehensive Stroke Center has earned the AHA’s Get With The Guidelines® - Stroke GoldPlus award.